| Katherine Nicholas Jacob, MD | |
|
1105 Central Expy N Ste 2360, Allen, TX 75013-6116 | |
| (214) 547-7557 | |
| (214) 547-7560 |
| Full Name | Katherine Nicholas Jacob |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1105 Central Expy N Ste 2360, Allen, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497780571 | NPI | - | NPPES |
| 0031MY | Other | TX | BLUE CROSS/BLUE SHIELD TX |
| 176680001 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | L2344 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Nicholas Jacob, MD 1105 Central Expy N Ste 2360, Allen, TX 75013-6116 Ph: (214) 547-7557 | Katherine Nicholas Jacob, MD 1105 Central Expy N Ste 2360, Allen, TX 75013-6116 Ph: (214) 547-7557 |
News Archive
Researchers at the Max F. Perutz Laboratories of the University of Vienna and the Medical University of Vienna as well as at the University of Natural Resources and Life Sciences in Vienna have discovered an entirely new aspect of gene regulation they call exitron splicing.
Hitachi Aloka Medical, Ltd. (Headquartered in Tokyo, Japan, President: Mr. Minoru Yoshizumi) and iVu Imaging Corporation announced the signing of an agreement making Hitachi Aloka Medical, Ltd. the exclusive global distributor of iVu's SOFIA system, an automated whole breast ultrasound scanner designed to enable the earlier detection of breast cancer in women with mammographically dense breasts.
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
IDEXX Laboratories, Inc., today reported that revenues for the fourth quarter of 2010 increased 5% to $283.8 million, from $270.3 million for the fourth quarter of 2009. Organic revenue growth, as defined below, was 6%. Earnings per diluted share ("EPS") for the quarter ended December 31, 2010 increased 22% to $0.62, compared to $0.51 for the same period in the prior year.
› Verified 2 days ago
Dr. Yamini K Maddala, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 981 State Highway 121, Suite 1140, Allen, TX 75013 Phone: 469-697-5100 Fax: 469-697-5105 | |
Kathryn Anne White, D.O. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1105 Central Expy N Ste 235, Allen, TX 75013 Phone: 972-747-6042 | |
Dr. Olubukola Aduke Okoro, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 997 Raintree Cir Ste 130, Allen, TX 75013 Phone: 763-443-3926 Fax: 972-390-1050 | |
Deepti Dhavaleshwar, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 981 State Highway 121, Suite 1140, Allen, TX 75013 Phone: 469-697-5100 Fax: 469-697-5105 | |
Asif A Muhammad, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 935 W Exchange Pkwy, Suite 100, Allen, TX 75013 Phone: 214-383-0938 Fax: 214-383-9851 | |
Dr. Teresa Dewlett Rajala, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1314 W Mcdermott Dr, Suite 106, Pmb 808, Allen, TX 75013 Phone: 469-252-0022 Fax: 214-383-9587 | |
Dr. Ferzana Mir, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1105 Central Expy N, Suite 2360, Allen, TX 75013 Phone: 972-838-1892 |